CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Casi Pharmaceuticals inc   (CASI)
Other Ticker:  
 
 

CASI's Revenue Growth by Quarter and Year

Casi Pharmaceuticals Inc 's Revenue results by quarter and year




CASI Revenue (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December 33.88 43.11 9.16 4.82
III Quarter September 0.00 0.00 8.11 4.24
II Quarter June 0.00 0.00 7.16 2.67
I Quarter March 0.00 0.00 5.74 3.41
FY   33.88 43.11 30.17 15.14



CASI Revenue fourth quarter 2023 Y/Y Growth Comment
Casi Pharmaceuticals Inc reported decline in Revenue in the fourth quarter 2023 by -21.41% to $ 33.88 millions, from the same quarter in 2022.
The contraction in the fourth quarter 2023 Casi Pharmaceuticals Inc 's Revenue compares unfavorably to the Company's average Revenue jump of 68.06%.

Looking into fourth quarter 2023 results within Major Pharmaceutical Preparations industry 133 other companies have achieved higher Revenue growth. While Casi Pharmaceuticals Inc ' s Revenue fall of -21.41% ranks overall at the positon no. 2791 in the fourth quarter 2023.


CASI Revenue ( Y/Y Growth %) 2023
 2022 2021 2020
IV Quarter December -21.41 % 370.63 % 90.04 % 230.14 %
III Quarter September - - 91.27 % 51.97 %
II Quarter June - - 168.16 % -
I Quarter March - - 68.33 % -
FY   -21.41 % 42.89 % 99.27 % 354.65 %

Financial Statements
Casi Pharmaceuticals Inc 's fourth quarter 2023 Revenue $ 33.88 millions CASI's Income Statement
Casi Pharmaceuticals Inc 's fourth quarter 2022 Revenue $ 43.11 millions Quarterly CASI's Income Statement
New: More CASI's historic Revenue Growth >>


CASI Revenue (Quarter on Quarter Growth %)

 2023
 2022 2021 2020
IV Quarter December - - 12.95 % 13.68 %
III Quarter September - - 13.27 % 58.8 %
II Quarter June - - 24.74 % -21.7 %
I Quarter March - - 19.09 % 133.56 %
FY (Year on Year)   -21.41 % 42.89 % 99.27 % 354.65 %


Explore CASI Customer Growth by Product and Service >> Back to CASI Growth rate Comparisons >>


Revenue fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #134
Healthcare Sector #363
Overall #2791

Revenue Y/Y Growth Statistics
High Average Low
370.7 % 68.06 % -100 %
(Dec 31 2022)   0
Revenue fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #134
Healthcare Sector #363
Overall #2791
Revenue Y/Y Growth Statistics
High Average Low
370.7 % 68.06 % -100 %
(Dec 31 2022)   0

Revenue by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Casi Pharmaceuticals Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CASI's IV. Quarter Q/Q Revenue Comment


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CASI's IV. Quarter Q/Q Revenue Comment


Casi Pharmaceuticals Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2023)		 12 Months Ending
0		 12 Months Ending
(Sep 30 2022)		 12 Months Ending
(Jun 30 2022)		 12 Months Ending
0
Cumulative Revenue 12 Months Ending $ 33.88 $ 0.00 $ 37.01 $ 34.91 $ 33.49
Y / Y Revenue Growth (TTM) -21.41 % - 43.26 % 58.93 % 91.71 %
Year on Year Revenue Growth Overall Ranking # 81 # 0 # 0 # 0 # 181
Seqeuential Revenue Change (TTM) -21.41 % - 6.02 % 4.21 % 11.02 %
Seq. Revenue Growth (TTM) Overall Ranking # 574 # 0 # 0 # 0 # 1404

New: More CASI's historic Revenue Growth >>



Cumulative Revenue growth Comment
Casi Pharmaceuticals Inc showed decline, but improvement compare to trailing twelve month Revenue decrease in 0. If the fiscal year would end in Dec 31 2023, Casi Pharmaceuticals Inc 's annual Revenue growth would be -21.41% year on year to $34 millions.

Among companies within the Healthcare sector 17 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 81.

Revenue TTM Q/Q Growth Statistics
High Average Low
547.46 %
156.05 %
-21.41 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 51
Healthcare Sector # 18
Overall # 81

Revenue TTM Y/Y Growth Statistics
High Average Low
547.46 %
156.05 %
-21.41 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 51
Sector # 123
S&P 500 # 574
Cumulative Revenue growth Comment
Casi Pharmaceuticals Inc showed decline, but improvement compare to trailing twelve month Revenue decrease in 0. If the fiscal year would end in Dec 31 2023, Casi Pharmaceuticals Inc 's annual Revenue fall would be -21.41% year on year to $34 millions.

Among companies within the Healthcare sector 17 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 81.

Revenue TTM Q/Q Growth Statistics
High Average Low
547.46 %
156.05 %
-21.41 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 51
Healthcare Sector # 18
Overall # 81

Revenue TTM Y/Y Growth Statistics
High Average Low
547.46 %
156.05 %
-21.41 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 51
Sector # 123
S&P 500 # 574




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
CASI's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for CASI's Competitors
Revenue Growth for Casi Pharmaceuticals Inc 's Suppliers
Revenue Growth for CASI's Customers

You may also want to know
CASI's Annual Growth Rates CASI's Profitability Ratios CASI's Asset Turnover Ratio CASI's Dividend Growth
CASI's Roe CASI's Valuation Ratios CASI's Financial Strength Ratios CASI's Dividend Payout Ratio
CASI's Roa CASI's Inventory Turnover Ratio CASI's Growth Rates CASI's Dividend Comparisons



Companies with similar Revenue fall for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2023
Healthcare Services Group Inc -0.04%$ -0.042 millions
Integra Lifesciences Holdings Corp-0.25%$ -0.247 millions
National Research Corporation-0.37%$ -0.375 millions
The Beauty Health Company-0.63%$ -0.633 millions
3m Company-0.82%$ -0.817 millions
Viatris Inc -1.00%$ -0.998 millions
Aspira Women s Health Inc -1.07%$ -1.068 millions
Quest Diagnostics Inc-1.93%$ -1.929 millions
Koru Medical Systems Inc -2.16%$ -2.161 millions
Envista Holdings Corporation-2.30%$ -2.300 millions
Zynex inc -3.11%$ -3.114 millions
Shl Telemedicine Ltd-3.26%$ -3.259 millions
Baxter International Inc -3.55%$ -3.550 millions
Caribou Biosciences Inc -3.63%$ -3.629 millions
Gilead Sciences Inc -3.72%$ -3.722 millions
Lifevantage Corp-3.92%$ -3.921 millions
Avantor Inc -4.02%$ -4.022 millions
Pressure Biosciences Inc -4.26%$ -4.257 millions
Journey Medical Corp-4.44%$ -4.441 millions
Escalon Medical Corp -4.53%$ -4.533 millions
Inovio Pharmaceuticals Inc -4.55%$ -4.553 millions
American Shared Hospital Services-4.73%$ -4.725 millions
Optinose Inc -4.76%$ -4.756 millions
Cryoport inc -5.13%$ -5.133 millions
Psychemedics Corporation-5.24%$ -5.243 millions
Hookipa Pharma inc -5.38%$ -5.378 millions
Abbvie Inc -5.42%$ -5.423 millions
Hologic Inc-5.69%$ -5.688 millions
Medicure Inc -5.94%$ -5.944 millions
Encision Inc -6.08%$ -6.083 millions


Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com